A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®

NCT06633783 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

370

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Semaglutide
DRUG: Semaglutide

Sponsor

Hangzhou Jiuyuan Gene Engineering Co. Ltd.,